<- Go Home

Check-Cap Ltd.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Market Cap

$3.9M

Volume

98.9K

Cash and Equivalents

$17.8M

EBITDA

-$13.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

N/A

Profit Margin

N/A

52 Week High

$3.04

52 Week Low

$0.56

Dividend

N/A

Price / Book Value

0.23

Price / Earnings

-0.31

Price / Tangible Book Value

0.23

Enterprise Value

-$13.9M

Enterprise Value / EBITDA

1.01

Operating Income

-$13.8M

Return on Equity

53.03%

Return on Assets

-33.21

Cash and Short Term Investments

$17.8M

Debt

N/A

Equity

$17.2M

Revenue

N/A

Unlevered FCF

-$10.5M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches